New combo tackles tough breast cancer brain tumors
NCT ID NCT03483012
First seen Jan 02, 2026 · Last updated May 23, 2026 · Updated 20 times
Summary
This study tested whether combining the drug atezolizumab with a precise type of radiation (stereotactic radiosurgery) could help control triple-negative breast cancer that has spread to the brain. Six participants with stage IV breast cancer took part. The goal was to see how long the cancer stayed under control and how well the treatment worked on tumors outside the brain.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Dana-Farber Cancer Institute
Boston, Massachusetts, 02215, United States
Conditions
Explore the condition pages connected to this study.